UCB (MEX:UCBN) Retained Earnings: MXN186,652 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:UCBN UCB SA MEX:UCBN
95 GF Score
Price MXN1,692.27
GF Value MXN1,905.79
View Full Analysis

What is UCB Retained Earnings?

UCB MEX:UCBN 95 Retained Earnings is MXN186,652 Mil as of Jun. 2026. GuruFocus rates MEX:UCBN with a GF Score™ of 95/100 and a GF Value™ of MXN1,905.79.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. UCB's retained earnings for the quarter that ended in Jun. 2026 was MXN186,652 Mil.

UCB's quarterly retained earnings increased from Jun. 2025 (MXN163,751 Mil) to Dec. 2025 (MXN182,988 Mil) and increased from Dec. 2025 (MXN182,988 Mil) to Jun. 2026 (MXN186,652 Mil).

UCB's annual retained earnings increased from Dec. 2023 (MXN121,763 Mil) to Dec. 2024 (MXN161,495 Mil) and increased from Dec. 2024 (MXN161,495 Mil) to Dec. 2025 (MXN182,988 Mil).


UCB  (MEX:UCBN) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


UCB Retained Earnings Historical Data

* Premium members only.

The historical data trend for UCB's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

UCB Retained Earnings Chart

UCB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 145,892.79 133,105.64 121,762.93 161,495.19 182,987.67

UCB Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 128,023.80 161,495.19 163,751.06 182,987.67 186,652.03
MEX:UCBN
95GF Score
UCB SA MEX:UCBN
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

UCB Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of MXN186,652 Mil mean?
UCB (MEX:UCBN) has a Retained Earnings of MXN186,652 Mil as of Jun. 2026. Retained earnings is the amount of net income not issued to shareholders. View historical data on UCB and its competitors.
Is UCB's Retained Earnings too high?
UCB's current Retained Earnings is MXN186,652 Mil. Overall, UCB has a GF Score™ of 95/100, reflecting its overall financial health beyond just this single metric.
How does UCB's Retained Earnings compare to VRTX and REGN?
UCB's Retained Earnings of MXN186,652 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Biotechnology company?
A good Retained Earnings depends on the Biotechnology industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on UCB and its competitors. UCB's current Retained Earnings is MXN186,652 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is UCB stock overvalued right now?
UCB (MEX:UCBN) has a current Retained Earnings of MXN186,652 Mil. The stock's GF Value™ is MXN1,905.79, compared to a current price of MXN1,692.27 — trading 11.2% below its estimated fair value. The current Retained Earnings is MXN186,652 Mil. UCB's overall GF Score™ is 95/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For UCB (MEX:UCBN), the current Retained Earnings is MXN186,652 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is UCB (MEX:UCBN) Overvalued in 2026?

Based on GuruFocus' analysis, UCB stock appears to be undervalued. The current stock price of MXN1,692.27 is trading 11.2% below its estimated GF Value™ of MXN1,905.79.

Key valuation signals for MEX:UCBN:

  • Retained Earnings: MXN186,652 Mil
  • GF Value™: MXN1,905.79 vs. price of MXN1,692.27 (11.2% below fair value)
  • GF Score™: 95/100

No single metric tells the full story. See the MEX:UCBN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


UCB Business Description

Address Allee de la Recherche, 60, Brussels, BEL, B-1070
UCB is a Belgium-based biopharma firm focused on the development of novel therapies for the treatment of central nervous system and immunologic diseases. Historically, revenue was derived from allergy medicine Zyrtec and epilepsy drug Keppra, which have both lost patent protection. The firm's key products are Cimzia (immunology), Vimpat (epilepsy), Neupro (Parkinson's disease and restless leg syndrome), Briviact (epilepsy), Bimzelx (psoriasis), Evenity (osteoporosis), Nayzilam (cluster seizures), Fintepla (Dravet Syndrome and Lennox-Gastaut Syndrome), and Kygevvi (rare mitochondrial disease).
95GF Score

Get the complete analysis for MEX:UCBN

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,692.27
Price
MXN1,905.79
GF Value